Member access

4-Traders Homepage  >  Shares  >  BOLSA DE VALORES DE SAO PAULO  >  Linx SA    LINX3   BRLINXACNOR0

LINX SA (LINX3)

0
End-of-day quote. End-of-day quote BOLSA DE VALORES DE SAO PAULO - 05/29
49.44 BRL   +1.08%
05/04 LINX : Tavcom and Linx International join forces
04/20 LINX : Ring of magnets new treatment for chronic acid reflux
04/15 APPLE : acquires Israeli co LinX Imaging for $20m
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector news 
The feature you requested does not exist. However, we suggest the following feature:

Linx : Torax Medical to Release Final Results of 5-Year Clinical Trial for LINX

05/26/2015 | 02:28am US/Eastern

Torax Medical reported the 5-year results from a landmark clinical trial of LINX, a solution for GERD, will be presented at the upcoming Digestive Diseases Week (DDW) being held in Washington, DC from May 16th - 20th.

Dr. Robert Ganz, MD, FASGE, Chief of Gastroenterology, Abbott- Northwestern Hospital and Associate Professor of Medicine, University of Minnesota will present the clinical results:

Long-Term Results Confirm Safety and Efficacy of a Magnetic Esophageal Device for GERD

Monday, May 18th

2:15 - 2:30 pm

Washington DC Convention Center

Patients included in this trial had abnormal levels of acid in the esophagus and were refractory to PPI therapy. The long-term efficacy endpoints evaluated at 5-years were control of reflux- related symptoms and elimination of dependence of PPI therapy.

"With the completion of this confirmatory study, the long-term safety and clinical benefits of the LINX procedure are now undeniable. The acceptance of LINX by patients and clinicians has been remarkable, and speaks to the need for a less invasive and non- disruptive treatment that corrects the esophageal sphincter defect, the root cause of reflux disease." said Todd Berg, President and CEO for Torax Medical.

LINX is a small implant comprised of interlinked titanium beads with magnetic cores. The magnetic attraction between the beads augments the existing esophageal sphincter's barrier function to prevent reflux. The device is implanted using a standard minimally invasive laparoscopic procedure and is an alternative to the more anatomically disruptive fundoplication, commonly used in surgical anti-reflux procedures. The LINX Reflux Management System is indicated for those patients diagnosed with GERD as defined by abnormal pH testing, and who continue to have chronic GERD symptoms despite maximum medical therapy for the treatment of reflux.

Torax Medical is a privately-held medical device company that develops and markets products designed to treat sphincter disorders utilizing its technology platform, Magnetic Sphincter Augmentation (MSA).

More Information:

http://www.linxforlife.com

http://www.toraxmedical.com

((Comments on this story may be sent to newsdesk@closeupmedia.com))

(c) 2015 ProQuest Information and Learning Company; All Rights Reserved., source Trade Publications

React to this article
Latest news on LINX SA
05/26 LINX : Torax Medical to Release Final Results of 5-Year Clinical Trial for LINX
05/15 LINX : Torax Medical to Release Final Results of 5-Year Clinical Trial for LINX
05/06 LINX : News in brief
05/04 LINX : Tavcom and Linx International join forces
05/03 LINX : Colorado Springs area business events starting May 3, 2015
04/22 LINX : Week if fun, games and gunge for children!
04/22 LINX : Breakfast and prayer on offer
04/20 LINX : Ring of magnets new treatment for chronic acid reflux
04/16 Future iPhones and iPads may come with 3D cameras
04/15 APPLE : acquires Israeli co LinX Imaging for $20m
Advertisement
Chart
Duration : Period :
Linx SA Technical Analysis Chart | LINX3 | BRLINXACNOR0 | 4-Traders
Income Statement Evolution
More Financials